share_log

Reliq Health Technologies, Inc. Announces Six New Contracts in CA, FL and NV

Reliq Health Technologies, Inc. Announces Six New Contracts in CA, FL and NV

Reliq Health Technologies, Inc. 宣佈在加利福尼亞州、佛羅里達州和內華達州
GlobeNewswire ·  2023/06/09 03:01

HAMILTON, Ontario, June 09, 2023 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) ("Reliq" or the "Company"), a rapidly growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has signed six new contracts with physician practices in California, Florida and Nevada. These new contracts are expected to add over 3,000 new patients to Reliq's iUGO Care platform by the end of Q1 calendar year 2024, at an average revenue of $65 per patient per month.

安大略省漢密爾頓,2023 年 6 月 9 日(GLOBE NEWSWIRE)— Reliq Health Technologies Inc.(TSXV: RHT 或 OTC: RQHTF 或 WKN: A2AJTB) (”Reliq“或者”公司“)是一家快速發展的全球醫療保健技術公司,爲數十億美元的醫療保健市場開發創新的虛擬醫療解決方案。該公司很高興地宣佈,它已與加利福尼亞州、佛羅里達州和內華達州的醫生診所簽署了六份新合同。預計到2024日曆年第一季度末,這些新合同將爲Reliq的iUGO Care平臺增加3,000多名新患者,每位患者每月的平均收入爲65美元。

"We are very pleased with our continued traction in California, Florida and Nevada," said Dr. Lisa Crossley, CEO at Reliq Health Technologies, Inc. "The southern US states are a particularly attractive market segment for Reliq due to demographics. With many older Americans choosing to move south in retirement, there is a very large population of Medicare-covered patients in these states who are eligible for Reliq's services. The three states where we have the largest number of patients – California, Florida and Texas – make up over 25% of the total US population, with over 90 million residents. The new clients will be using the iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) modules to improve health outcomes and reduce the cost of care for their chronic disease patients. We expect to add over 3,000 patients to the iUGO Care platform by the end of March 2024 through these contracts, at an average of $65 per patient per month with an expected 75% gross margin. All six practices will go live next month."

“我們對我們在加利福尼亞州、佛羅里達州和內華達州的持續關注感到非常滿意,” Reliq Health Technologies, Inc.首席執行官麗莎·克羅斯利博士說,“由於人口結構原因,美國南部各州是Reliq特別有吸引力的細分市場。隨着許多美國老年人在退休後選擇向南移動,這些州有大量的醫療保險承保患者有資格獲得Reliq的服務。我們患者人數最多的三個州——加利福尼亞州、佛羅里達州和德克薩斯州——佔美國總人口的25%以上,居民超過9000萬。新客戶將使用iUGO Care遠程患者監測(RPM)、慢性護理管理(CCM)和行爲健康整合(BHI)模塊來改善健康結果並降低慢性病患者的護理成本。我們預計,到2024年3月底,通過這些合同,iUGO Care平臺將增加3,000多名患者,平均每位患者每月65美元,預計毛利率爲75%。所有六種做法將在下個月上線。”

Reliq Health

Reliq 健康

Reliq Health Technologies is a rapidly growing global healthcare technology company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq's powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the WKN:A2AJTB.

Reliq Health Technologies是一家快速發展的全球醫療保健技術公司,專門爲數十億美元的醫療保健市場開發創新的虛擬醫療解決方案。Reliq 強大的 iUGO Care 平臺支持護理協調和基於社區的虛擬醫療保健。iUgo Care 允許複雜患者在家接受高質量的護理,改善健康結果,提高患者和家屬的生活質量並降低醫療服務提供成本。iUgo Care 提供對遠程患者監測數據的實時訪問,使護理團隊能夠及時進行干預,防止昂貴的再入院和急診就診。Reliq Health Technologies在多倫多證券交易所風險投資公司上市,股票代碼爲RHT,在場外交易所交易代碼爲RQHTF,在法蘭克福證券交易所上市,代碼爲WKN: A2AJTB。

ON BEHALF OF THE BOARD
"Dr. Lisa Crossley"
CEO and Director

代表董事會
“麗莎·克羅斯利博士”
首席執行官兼董事

For further information please contact:

欲瞭解更多信息,請聯繫:

Company Contact
Investor Relations at ir@reliqhealth.com

公司聯繫人
投資者關係部位於 ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

美國投資者關係聯繫人
投資者關係
萊瑟姆合夥人有限責任公司
本·沙姆西安
紐約 | 菲尼克斯
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

多倫多證券交易所風險投資交易所及其監管服務提供商(該術語在多倫多證券交易所風險投資交易所的政策中定義)均不對本新聞稿的充分性或準確性承擔責任。

Cautionary Statements Regarding Forward Looking Information

關於前瞻性信息的警示聲明

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

根據適用的證券法的規定,本新聞稿中的某些陳述構成前瞻性陳述。所有非歷史事實的陳述,包括但不限於有關未來估計、計劃、計劃、預測、目標、假設、預期或未來業績信念的陳述,均爲 “前瞻性陳述”。

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

我們提醒您,此類 “前瞻性陳述” 涉及已知和未知的風險和不確定性,可能導致實際和未來事件與此類陳述中的預期存在重大差異。

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

前瞻性陳述包括但不限於與商業運營有關的陳述,包括技術開發、預期收入、預計市場規模以及其他基於未來業績預測、尚未確定的金額估計和管理假設的信息。

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

Reliq Health Technologies In公司“) 除非法律要求,否則不打算也不承擔任何義務更新這些前瞻性陳述。這些前瞻性陳述涉及與技術開發和營銷活動、公司在技術開發方面的歷史經驗、未投保的風險等有關的風險和不確定性。實際結果可能與此類前瞻性陳述所表達或暗示的結果存在重大差異。

SOURCE: Reliq Health Technologies Inc.

資料來源:Reliq 健康科技公司


声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論